Quidel Prices Senior Notes Offering | GenomeWeb

NEW YORK (GenomeWeb) — Quidel today announced the pricing of its previously announced underwritten public offering of $150 million in convertible senior notes due 2020.

The notes will pay interest at a rate of 3.25 percent per year, payable semiannually on June 15 and Dec. 15 of each year, beginning on June 15, 2015. The notes will mature on Dec. 15, 2020, unless earlier repurchased by Quidel or converted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.